Patents by Inventor Stephen D. Hurst

Stephen D. Hurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
    Publication number: 20120141411
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: January 25, 2012
    Publication date: June 7, 2012
    Applicant: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
    Publication number: 20110223130
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: April 20, 2011
    Publication date: September 15, 2011
    Applicant: Schering Corporation
    Inventors: STEPHEN D. HURST, Sandra M. Zurawski, Donna M. Rennick
  • POLYPEPTIDES THAT BIND BR3 AND USES THEREOF
    Publication number: 20100280227
    Abstract: The present invention relates to novel BR3 binding antibodies and polypeptides, including antagonist and agonist polypeptides. The present invention also relates to the use of the BR3 binding antibodies and polypeptides in, e.g., methods of treatment, screening methods, diagnostic methods, assays and protein purification methods.
    Type: Application
    Filed: July 13, 2010
    Publication date: November 4, 2010
    Applicant: GENENTECH, INC.
    Inventors: CHRISTINE M. AMBROSE, MERCEDESZ BALAZS, LAURA DEFORGE, MARK S. DENNIS, GERMAINE FUH, STEPHEN D. HURST, CHINGWEI V. LEE, HENRY B. LOWMAN, FLAVIUS MARTIN, GERALD R. NAKAMURA, DHAYA SESHASAYEE, MELISSA A. STAROVASNIK, JEFFREY S. THOMPSON
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A TH2 IMMUNE RESPONSE
    Publication number: 20100136020
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: November 6, 2009
    Publication date: June 3, 2010
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
    Publication number: 20090263401
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: December 17, 2007
    Publication date: October 22, 2009
    Applicant: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Polypeptides That Bind Br3 and Uses Thereof
    Publication number: 20080181888
    Abstract: The present invention relates to novel BR3 binding antibodies and polypeptides, including antagonist and agonist polypeptides. The present invention also relates to the use of the BR3 binding antibodies and polypeptides in, e.g., methods of treatment, screening methods, diagnostic methods, assays and protein purification methods.
    Type: Application
    Filed: December 23, 2005
    Publication date: July 31, 2008
    Inventors: Christine M. Ambrose, Mercedesz Balazs, Laura DeForge, Mark S. Dennis, Germaine Fuh, Stephen D. Hurst, Chingwei V. Lee, Henry B. Lowman, Flavius Martin, Gerald R. Nakamura, Dhaya Seshasayee, Melissa Starovasnik, Jeffrey S. Thompson
  • Uses of IL-174 for treating helminth infections
    Patent number: 7357924
    Abstract: Use of the cytokine designated IL-174 to treat infectious diseases such as helminth infections.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: April 15, 2008
    Assignee: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Cytokine uses; compositions; methods
    Publication number: 20040076608
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 22, 2004
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Methods of modulating IL-174 response
    Patent number: 6676939
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: January 13, 2004
    Assignee: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • METHODS OF MODULATING IL- 174 RESPONSE
    Publication number: 20030165460
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: April 17, 2001
    Publication date: September 4, 2003
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick